IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
98.72
-1.38 (-1.38%)
At close: Mar 6, 2026, 4:00 PM EST
97.50
-1.22 (-1.24%)
After-hours: Mar 6, 2026, 7:55 PM EST
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for IRADIMED CORPORATION.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for IRADIMED CORPORATION.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Reiterates $60 → $72 | Strong Buy | Reiterates | $60 → $72 | -27.07% | Feb 14, 2025 |
| Roth MKM | Roth MKM | Strong Buy Maintains $65 → $60 | Strong Buy | Maintains | $65 → $60 | -39.22% | Aug 2, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | -34.16% | Apr 22, 2024 |
| Roth Capital | Roth Capital | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | -63.53% | Aug 2, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | -83.79% | Oct 31, 2017 |
Financial Forecast
Revenue This Year
93.86M
from 83.81M
Increased by 11.99%
Revenue Next Year
103.16M
from 93.86M
Increased by 9.91%
EPS This Year
2.12
from 1.75
Increased by 21.23%
EPS Next Year
2.37
from 2.12
Increased by 11.54%
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 97.5M | 107.4M |
| Avg | 93.9M | 103.2M |
| Low | 89.4M | 98.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 16.3% | 14.4% |
| Avg | 12.0% | 9.9% |
| Low | 6.6% | 4.4% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 2.21 | 2.44 |
| Avg | 2.12 | 2.37 |
| Low | 2.02 | 2.27 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 26.0% | 14.8% |
| Avg | 21.2% | 11.5% |
| Low | 15.4% | 7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.